Skip to content
HowShorted

LENZ Therapeutics, Inc. short interest in 2026

In 2026, LENZ Therapeutics, Inc.'s disclosed short interest ran from 27.89% of shares outstanding on 15 Jan 2026 to 33.83% on 15 Sep 2026, a change of +5.94 percentage points. The year's high was 37.83% on 15 Jul 2026 and its low 23.21% on 30 Jan 2026, averaging 31.93% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.31 days on 15 Jun 2026. Full history: LENZ Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for LENZ Therapeutics, Inc. in 2026

2026 in figures

Start of year
27.89% (15 Jan 2026)
End of year
33.83% (15 Sep 2026)
Change
+5.94 pp
High
37.83% (15 Jul 2026)
Low
23.21% (30 Jan 2026)
Average
31.93%
Highest days to cover
20.31 (15 Jun 2026)
SEC filings marked
7

Every report in 2026

LENZ Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202627.89%7.68results (8-K)
30 Jan 202623.21%5.51
13 Feb 202626.95%9.39
27 Feb 202628.45%12.85
13 Mar 202630.72%14.08
31 Mar 202628.81%5.8710-K filed, results (8-K)
15 Apr 202630.23%13.90
30 Apr 202634.20%14.22
15 May 202635.39%11.0210-Q filed, results (8-K)
29 May 202632.63%12.63
15 Jun 202633.10%20.31
30 Jun 202633.27%11.03
15 Jul 202637.83%10.46
31 Jul 202636.10%11.82
14 Aug 202635.63%12.5310-Q filed, results (8-K)
31 Aug 202634.61%18.89
15 Sep 202633.83%14.55

See also: LENZ Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.